Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arich Enterprise CoROCO:4173 +0.28%66 EBITDA Margin % is 8.42% as of Dec. 2025, which is 26% below its 10-year median of 11.32. GuruFocus rates ROCO:4173 with a GF Score™ of 66/100 and a GF Value™ of NT$30.43 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Arich Enterprise Co ranks better than 55.11% on this metric.
Arich Enterprise Co (ROCO:4173) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Arich Enterprise Co EBITDA Margin % Related Terms
Arich Enterprise Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Arich Enterprise Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arich Enterprise Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Arich Enterprise Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co (ROCO:4173) has a EBITDA Margin % of 8.42% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Arich Enterprise Co and its competitors. This is 26% below median its historical median of 11.32. Over the past decade, Arich Enterprise Co's EBITDA Margin % has ranged from 2.00 to 13.07. According to the industry distribution chart, Arich Enterprise Co ranks #299 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 44.9%.
Is Arich Enterprise Co's EBITDA Margin % too high?
Arich Enterprise Co's current EBITDA Margin % of 8.42% is 26% below median its 10-year median of 11.32. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 13.07. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Arich Enterprise Co's value of 8.42% is 17.7% below this industry median. Based on the distribution chart, Arich Enterprise Co ranks #299 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Arich Enterprise Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arich Enterprise Co's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Arich Enterprise Co ranks #299 out of 666 companies for EBITDA Margin %. This puts Arich Enterprise Co in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Arich Enterprise Co's value of 8.42% is 17.7% below this benchmark. Historically, Arich Enterprise Co's own EBITDA Margin % has ranged from 2.00 to 13.07 over the past decade. While the company's 10-year median is 11.32 vs. the industry median of 10.24, Arich Enterprise Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arich Enterprise Co's current EBITDA Margin % of 8.42% is 17.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Arich Enterprise Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arich Enterprise Co's current EBITDA Margin % is 8.42%, which is 26% below median its own 10-year median of 11.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arich Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Arich Enterprise Co (ROCO:4173) is currently considered Possible Value Trap. The stock's GF Value™ is NT$30.43, compared to a current price of NT$18.00 — trading 40.8% below its estimated fair value. The current EBITDA Margin % is 8.42%, which is 26% below median its 10-year median of 11.32 and 17.7% below the Healthcare Providers & Services industry median of 10.24. Arich Enterprise Co's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Arich Enterprise Co (ROCO:4173), the current EBITDA Margin % is 8.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arich Enterprise Co (ROCO:4173) Overvalued in 2026?
Based on GuruFocus' analysis, Arich Enterprise Co stock appears to be undervalued.
The current stock price of NT$18.00 is trading 40.8% below its estimated GF Value™ of NT$30.43.
GuruFocus considers Arich Enterprise Co to be Possible Value Trap.
Key valuation signals for ROCO:4173:
EBITDA Margin %: 8.42% (26% below median its 10-year median of 11.32)
GF Value™: NT$30.43 vs. price of NT$18.00 (40.8% below fair value)
Industry Position: 17.7% below the Healthcare Providers & Services median (#299 of 666)
No single metric tells the full story. See the ROCO:4173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
66GF Score
Get the complete analysis for ROCO:4173
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4173 has been successfully added to your 
